JADA System (postpartum hemorrhage control device)
- Agency
- Indian Health Service Behavioral Health Programs
- Office
- OKLAHOMA CITY, USA
- Solicitation number
- IHS102027
- NAICS
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Posted
- 2026-09-18
- Deadline
- 2026-10-05
- Place of performance
- Oklahoma City, Oklahoma 73114, UNITED STATES
Description
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations.
Pursuant to 48 CFR Part 326, Subpart 326.603-3 and IHM 5.5-6, the Indian Health Service (IHS) must use the negotiation authority of the Buy Indian Act, 25 U.S.C. 47, to give preference to Indian Economic Enterprises (IEE) whenever the use of that authority is authorized and practicable.
The Government is seeking to identify Indian Small Business Economic Enterprises (ISBEEs) capable of performing the below Indian Health Service (IHS) requirement for JADA System (postpartum hemorrhage control device). Any vendor responding to this notice should submit their capability statement as well as the Buy Indian Act Indian Economic Enterprise Representation Form (attached). Instructions for submission are outlined below.
Indian Small Business Economic Enterprises (ISBEEs) and other small business are highly encouraged to respond to this notice. However, firms should understand that generic capability statements are not sufficient for effective evaluation of their capacity and capability to perform the work required. Responses must directly demonstrate the company's capability, experience, and ability to provide new JADA System or equivalent FDA-cleared successor product. The delivery locations are: NSSC - DISTRIBUTION CENTER 501 NE 122nd St. Suite F Oklahoma City, OK 73114; NSSC I-35 8601 N I-35 Service Road Oklahoma City, OK 73131; NSSC-Gallup 2400 FUHS Avenue Building 10 Gallup, NM 87301.